Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Complementary Therapies in Medicine

Volumn 21, Issue 5, 2013, Pages 447-452

  Fallah Huseini, Hassan ^a   Hasani Rnjbar, Shirin ^b,c   Nayebi, Neda ^c   Heshmat, Ramin ^c   Sigaroodi, Farahnaz Khaliqi ^a   Ahvazi, Maryam ^a   Alaei, Behroz Abbasi ^d   Kianbakht, Saeed ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Diabetic Patient Association   (Iran)

Author keywords

Capparis spinosa; Clinical trial; Diabetes; Medicinal plants

Indexed keywords

ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CAPPARIS SPINOSA EXTRACT; CREATININE; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; NITROGEN; PLACEBO; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CAPPARIS SPINOSA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

CAPPARIS SPINOSA; CLINICAL TRIAL; DIABETES; MEDICINAL PLANTS;

BLOOD GLUCOSE; CAPPARIS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FRUIT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IRAN; KIDNEY FUNCTION TESTS; LIPIDS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84884130936     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2013.07.003     Document Type: Article

References (31)

1. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 2008, 358(24):2545-2559.
2. Hasani-Ranjbar S., Larijani B., Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Archives of Medical Science 2008, 4(3):285-292.
3. Nahas R., Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Canadian Family Physician 2009, 55(6):591-596.
4. Inocencio C.F., Alcaraz F., Calderón C., Obón D., Rivera R. The use of floral characters in Capparis sect. Capparis' to determine the botanical and geographical origin of capers. European Food Research and Technology 2002, 214(4):335-339.
5. Yaniv Z.A., Dafni J., Friedman D., Palevitch B. Plants used for the treatment of diabetes in Israel. Journal of Ethnopharmacology 1987, 2:145-151.
6. Bnouham M., Mekhfi H., Abdelkhaleq L.A., Ziyyat A. Ethnopharmacology forum. Medicinal plants used in the treatment of diabetes in Morocco. International Journal of Diabetes and Metabolism 2002, 10:33-50.
7. Afifi-Yazar F.U., Kasabri V., Abu-Dahab R. Medicinal plants from Jordan in the treatment of diabetes: traditional uses vs. in vitro and in vivo evaluations - part 2. Planta Medica 2011, 77(11):1210-1220.
8. Eddouks M., Lemhadri A., Michel J.B. Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats. Journal of Ethnopharmacology 2004, 94(1):143-148.
9. Eddouks M., Lemhadri A., Michel J.B. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. Journal of Ethnopharmacology 2005, 98(3):345-350.
10. Yoo K.M., Lee C.H., Lee H., Moon B., Lee C.Y. Relative antioxidant and cytoprotective activities of common herbs. Food Chemistry 2008, 106:929-936.
11. Kim D.O., Jeong S.W., Lee C.Y. Antioxidant capacity of phenolic phytochemicals from various cultivars of plums. Food Chemistry 2003, 81:321-326.
12. American Diabetes Association Screening for type 2 diabetes. Diabetes Care 2003, 26(S1):21-24.
13. Lemhadri A., Eddouks M., Sulpice T., Burcelin R. Anti-hyperglycaemic and antiobesity effects of Capparis spinosa and Chamaemelum nobile aqueous extracts in HFD mice. American Journal of Pharmacology and Toxicology 2007, 2(3):106-110.
14. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51:7-18.
15. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
16. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes/Metabolism Research and Reviews 2001, 17:189-212.
17. Paolisso G., Giugliano D. Oxidative stress and insulin action, is there a relationship?. Diabetologia 1996, 39:357-363.
18. Montonen J., Knekt P., Järvinen R., Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004, 27(2):362-366.
19. Fallah Huseini H., Larijani B., Fakhrzadeh H., Radjabipour B., Toliat T., Reza M. The efficacy of Silybum marianum (L.) Gaertn, (silymarin) in the treatment of type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research 2006, 20(12):1036-1039.
20. Ruhe R.C., McDonald B.R. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. Journal of the American College of Nutrition 2001, 20(5):363-369.
21. Yang Y.U., Gao H., Tang Z., Song X., Lijun W.U. Several phenolic acids from the fruit of Capparis spinosa. Asian Journal of Traditional Medicines 2006, 1:3-4.
22. Yang T., Liu Y.Q., Wang C.H., Wang Z.T. Advances on investigation of chemical constituents, pharmacological activities and clinical applications of Capparis spinosa. Zhongguo Zhong Yao Za Zhi 2008, 33(21):2453-2458.
23. Yang T., Liu Y.Q., Chou C.H.G., Cheng X., Wang Z.A. New antioxidant compound from Capparis spinosa. Pharmaceutical Biology 2010, 48(5):589-594.
24. Tlili N., Khaldi A., Triki S., Munné-Bosch S. Phenolic compounds and vitamin antioxidants of caper (Capparis spinosa). Plant Foods for Human Nutrition 2010, 65(3):260-265.
25. Ramezani Z., Aghel N., Keyghobadi H. Rutin from different parts of Capparis spinosa growing wild in Khuzestan/Iran. Pakistan Journal of Biological Sciences 2008, 11(5):768-772.
26. Lam S.K., Han Q.F. Isolation and characterization of a lectin with potentially exploitable activities from caper (Capparis spinosa) seeds. Bioscience Reports 2009, 29(5):293-299.
27. Stanley M.P.P., Kamalakkannan N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. Journal of Biochemical and Molecular Toxicology 2006, 20(2):96-102.
28. Kolb H., Oschilewski M., Schwab E., Greulich B., Roos P., Kiesel U. Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins. Diabetes Research 1986, 3(4):183-186.
29. Rajesh P.P., Selvamani S., Latha A., Saraswathy V., Kannan R. A review on chemical and medicobiological applications of Capparidaceae family. Pharmacognosy Reviews 2009, 3:378-387.
30. Ozcan M.M. Investigation on the mineral contents of capers (Capparis spinosa) seed oils growing wild in Turkey. Journal of Medicinal Food 2008, 11(3):596-599.
31. Triggiani V., Resta F., Guastamacchia E., Sabbà C., Licchelli B., Ghiyasaldin S., et al. Role of antioxidants, essential fatty acids, carnitine, vitamins, phytochemicals and trace elements in the treatment of diabetes mellitus and its chronic complications. Endocrine, Metabolic & Immune Disorders - Drug Targets 2006, 6(1):77-93.